Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - International Stem Cell CORP | d270049d10k.htm |
| EX-23.1 - CONSENT OF MAYER HOFFMANN MCCANN P.C. - International Stem Cell CORP | d270049dex231.htm |
| EX-31.1 - CERTIFICATION - International Stem Cell CORP | d270049dex311.htm |
| EX-31.2 - CERTIFICATION - International Stem Cell CORP | d270049dex312.htm |
| EX-23.2 - CONSENT OF VASQUEZ & COMPANY LLP - International Stem Cell CORP | d270049dex232.htm |
| EX-32.1 - CERTIFICATION - International Stem Cell CORP | d270049dex321.htm |
| EXCEL - IDEA: XBRL DOCUMENT - International Stem Cell CORP | Financial_Report.xls |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of International Stem Cell Corporation (the “Company”) on Form 10-K for the year ended December 31, 2011 as filed with the Securities and Exchange Commission on March 16, 2012 (the “Report”), I, Linh T. Nguyen, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 16, 2012
| /s/ Linh T. Nguyen |
| Linh T. Nguyen Chief Financial Officer (Principal Financial and Accounting Officer) |